Eliminating Viral Hepatitis by 2030

Eliminating Viral Hepatitis by 2030

In 2016, 194 governments vowed to eliminate hepatitis B and C as a public health threat by 2030

The World Hepatitis Alliance is fighting to make it a reality

In 2016, the single greatest global commitment in viral hepatitis was made when 194 governments adopted the WHO’s Global Health Sector Strategy (GHSS) on Viral Hepatitis, which sets a goal of eliminating hepatitis B and C as a public health threat by 2030.

The Strategy, which comes as a response to the Sustainable Development Goals, includes ambitious targets and interventions, which, if reached will reduce the number of deaths by 65% and increase treatment rates from 1% to 80%, saving 7.1 million lives globally by 2030. 

We have set the elimination of viral hepatitis as our priority and are undertaking various activities to ensure it becomes a reality:

NOhep

NOhep is a global grassroots movement aimed at bringing all stakeholders together to eliminate viral hepatitis by 2030. Launched in 2016, NOhep firmly positions itself at the forefront of the elimination conversation, showcasing exemplary leadership, fostering on the ground innovative solutions and taking action to support the policy change needed to eliminate the cancer-causing illness by 2030.

Being a part of NOhep means being part of the solution, because only together can we achieve a world with NOhep. Together with our members we are committed to grow the movement by continuing to provide the secretariat, secure financial resources and build strategic efforts.

To find out more about the development of NOhep and its global launch, watch this short video. You can also follow us on Twitter / Facebook and sign up to NOhep here.

Why eliminating viral hepatitis is key to achieving the Sustainable Development Goals

In 2000, the global health community failed to recognise viral hepatitis as a major hindrance to development. As a result it did not appear in the Millennium Development Goals. Fifteen years later it finally got the recognition it deserves and was officially acknowledged as a global health and development priority when more than 160 global leaders signed up to 17 Sustainable Development Goals to protect the planet and ensure prosperity for all as part of a new sustainable agenda.

Viral hepatitis was included as a focus area in the health related goal – Goal 3.3 – with world leaders pledging to ‘combat’ it by 2030. In response, WHO drafted the Global Viral Hepatitis Strategy which was then subsequently adopted in 2016 by all of its Member States. This Strategy carries ambitious targets which if reached will reduce the number of deaths by 65% and increase treatment rates from 1% to 80%, saving 7.1 million lives globally by 2030! Find out more about how eliminating viral hepatitis is key to achieving the SDGs.

HOLDING GOVERNMENTS ACCOUNTABLE

Without purposeful implementation even the best strategy will be worthless. This is why it is so important to hold governments accountable for their level of responsiveness in terms of policy decisions and front-line processes and to ensure they are equipped to meet the goals and targets outlined in the Global Viral Hepatitis Strategy. 

To that end, we are working with WHO to assess governments’ response to the epidemic through a Member State comprehensive survey. WHO will publish the results in a report entitled “Country Response Profile on viral hepatitis B and C (2016 - 2017)”, which will be launched in 2017. In parallel to this, we are conducting our own civil society survey to gauge what is REALLY happening on the ground from the perspective of our NGO members.

The areas of focus for our civil society survey are:

  • the level of our members’ engagement in their government’s response to viral hepatitis
  • the level of stigma and discrimination affecting people living with viral hepatitis in their country and what their government is doing about it
  • the level of access to diagnostics and treatment

If you are a WHA member and haven't completed the survery, click here.

Findings will also be released in 2017. 

STRENGTHENING OUR MEMBERS' VOICES

After years of neglect, viral hepatitis is finally enjoying a moment in the spotlight thanks to a confluence of innovations and recent clinical advances and to our collective advocacy work. Advocacy got us where we are today and advocacy will be key to reaching elimination by 2030. This is why we are continually striving to tackle the obstacles that inhibit our members from making an even bigger impact on the ground and build their capacity and capability so that the patients’ voice is heard. Find out more here.

MAKING THE ECONOMIC AND DEVELOPMENT CASE FOR VIRAL HEPATITIS

In a world filled with competing priorities and shrinking sources of funding, we need to show governments and global bodies that eliminating viral hepatitis makes sense. To that end, we have embarked on the ambitious task of making the economic and development case for viral hepatitis and convincing governments that elimination is indeed within their reach by offering incentive and tangible solutions. Stay tuned for updates.